Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 2575 of 3173 entries
View as:

Study To Assess The Effect Of Gabapentin, Diphenhydramine And Morphine On Cold Pain In Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01119222 Org: User:
Start: 07/31/08 End: 10/31/08 Due: 10/31/09

CARDS Is Designed To Show If Lowering Cholesterol With Atorvastatin In Type 2 Diabetics Without CV Disease Reduces The Risk Of CV Events

Phase: N/A Priority: Normal
NCT ID: NCT00327418 Org: User:
Start: 01/31/97 End: 02/29/04 Due: 02/28/05

Study Of Tranexamic Acid For The Reduction Of Blood Loss In Patients Undergoing Major Abdominal Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00827931 Org: User:
Start: 09/30/09 End: 05/31/11 Due: 05/31/12

First in Patient Study for PF-06840003 in Malignant Gliomas

Phase: N/A Priority: Normal
NCT ID: NCT02764151 Org: User:
Start: 09/09/16 End: 12/26/18 Due: 12/26/19

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of PF-06649751 in Subjects With Idiopathic Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT02373072 Org: User:
Start: 03/31/15 End: 03/31/16 Due: 03/31/17

A Study to Evaluate the Effect of the Experimental GLP-1 Drug PF-07081532 on Blood Levels of Common Birth Control Pills, and Drugs Omeprazole and Midazolam, and Effect of GLP-1 Drug Semaglutide on Midazolam Blood Levels in Healthy Adults With Weight in the Obesity Range

Phase: N/A Priority: Normal
NCT ID: NCT05671653 Org: User:
Start: 01/19/23 End: 11/03/23 Due: 11/03/24

A Study of PF-05175157 in Healthy Volunteers and Type 2 Diabetic Patients

Phase: N/A Priority: Normal
NCT ID: NCT01396161 Org: User:
Start: 07/31/11 End: 02/29/12 Due: 02/28/13

To Evaluate Long-Term Safety and Efficacy of Pregabalin in the Treatment of Neuropathic Pain After Spinal Cord Injury.

Phase: N/A Priority: Normal
NCT ID: NCT00141375 Org: User:
Start: 08/31/02 End: 01/31/06 Due: 01/31/07

Long Term Extension Study Evaluating Safety, Tolerability And Immunogenicity Of ACC-001 In Japanese Subjects With Mild To Moderate Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT01238991 Org: User:
Start: 12/31/10 End: 12/31/13 Due: 12/31/14

Estimate The Effect Of Lersivirine On The Pharmacokinetics Of S- And R-Methadone

Phase: N/A Priority: Normal
NCT ID: NCT01099748 Org: User:
Start: 05/31/10 End: 06/30/10 Due: 06/30/11

Study Of The Effects Of Atorvastatin On Cholesterol Levels In Rheumatoid Arthritis Patients Taking CP-690,550

Phase: N/A Priority: Normal
NCT ID: NCT01059864 Org: User:
Start: 02/28/10 End: 11/30/10 Due: 11/30/11

A Study Of Kappa Opioid Receptor Occupancy Of PF-04455242, Using PET (Positron Emission Tomography)

Phase: N/A Priority: Normal
NCT ID: NCT00939887 Org: User:
Start: 09/30/09 End: 12/31/09 Due: 12/31/10

A Phase 1 Trial To Assess The Safety And Pharmacokinetics Of Single, Ascending, Oral Doses Of Dimebon In Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT00907322 Org: User:
Start: 06/30/09 End: 07/31/09 Due: 07/31/10

Tofacitinib Ointment For Chronic Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT01831466 Org: User:
Start: 05/31/13 End: 09/30/14 Due: 09/30/15

Collection of Follow-up Data From CP-690,550-treated Kidney Transplant Recipients

Phase: N/A Priority: Normal
NCT ID: NCT01375127 Org: User:
Start: 08/31/11 End: 07/31/12 Due: 07/31/13

A Study to Learn How Different Amounts of the Study Medicine Called PF-07976016 Are Tolerated and Act in The Body in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT06106009 Org: User:
Start: 10/27/23 End: 08/19/24 Due: 08/19/25

Quillivant Oral Suspension (Quillivant XR) in the Treatment of Attention Deficit Hyperactivity Disorder (ADHD)

Phase: N/A Priority: Normal
NCT ID: NCT00904670 Org: User:
Start: 04/30/09 End: 08/31/09 Due: 08/31/10

Research Of Quality Of Life And Safety Outcomes Of Postmenopausal Breast Cancer Patients Switching From Tamoxifen Therapy To Aromatase Inhibitor Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00784888 Org: User:
Start: 06/30/08 End: 12/31/11 Due: 12/31/12

Tofacitinib (Xeljanz) Special Investigation for Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01932372 Org: User:
Start: 07/26/13 End: 08/24/21 Due: 08/24/22

Tofacitinib Ointment For Atopic Dermatitis (Atopic Eczema)

Phase: N/A Priority: Normal
NCT ID: NCT02001181 Org: User:
Start: 12/31/13 End: 09/30/14 Due: 09/30/15

A Study to Assess Efficacy and Safety of PF-06462700 in Japanese Participants With Aplastic Anemia

Phase: N/A Priority: Normal
NCT ID: NCT04350606 Org: User:
Start: 07/25/20 End: 04/19/21 Due: 04/19/22

Open-Label Drug Interaction Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) 100mg On The Pharmacokinetics Of Tamoxifen When Coadministered To Healthy Post-Menopausal Female Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01189500 Org: User:
Start: 08/31/10 End: 10/31/10 Due: 10/31/11

Safety And Tolerability Study Of BID Titration Scheme With PF-05089771

Phase: N/A Priority: Normal
NCT ID: NCT01772264 Org: User:
Start: 01/31/13 End: 04/30/13 Due: 04/30/14

Study To Evaluate The Safety, Pharmacokinetics, And Pharmacodynamics Of PF-00299804 In Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00225121 Org: User:
Start: 10/11/05 End: 09/23/10 Due: 09/23/11

Safety Study of a Vaccine to Help Protect Against Lyme Disease in Healthy Children

Phase: N/A Priority: Normal
NCT ID: NCT05634811 Org: User:
Start: 12/12/22 End: 07/24/25 Due: 07/24/26